Board of Directors

Erik Nerpin

Chairman

Born in 1961. Lawyer. Self-employed with Advokatfirman Nerpin AB. Independent of the Company and its principal owners. Chairman since March 2015, Board member since 2012. Other assignments include: Chairman of Kancera AB and Blasieholmen Investment Group B and Board member of Niccocino Holding and Effnetplattformen AB.

Holdings in Diamyd Medical as of August 31, 2016: 20 533 B shares.

Anders Essen-Möller

Board Member

Born in 1941. M.Sc. Founder of and CEO during 1996-2007 of Diamyd Medical and Chairman 2007 –2015. Founder of Synectics Medical AB, sold to Medtronic, Inc. in 1996. Chairman of the associated company NextCell Pharma AB.

Holdings in Diamyd Medical as of August 31, 2016: 1 278 112 A shares, 3 666 521 B shares.

Maria-Teresa Essen-Möller

Board Member

Born in 1970. M.Sc. in Business Administration. Digital Marketing Manager at Sanofi. Board member since 2009. Account Director at Creuna 2011-2014. Head of Investor Relations and Corporate Communications in former Diamyd Medical during 1997-1999.

Holdings in Diamyd Medical as of August 31, 2016: 32 000 B shares.

Torbjörn Bäckström

Board Member

Born in 1948. MD, PhD. CEO of Umecrine AB. Head of Neurosteroid Research Centre in Umeå and Senior Professor in the Department of Clinical Science, Obstetrics and Gynecology at Umeå University.

Holdings in Diamyd Medical as of January 9, 2017: 0.

Management

Ulf Hannelius

CEO

Born in 1975. PhD in Molecular Biology from the Karolinska Institutet in Stockholm and Executive MBA from Stockholm School of Economics. Prior experience from business development in the biotech and medtech industries as well as from academic research in the fields of genetics and molecular biology. Joined Diamyd Medical in 2015.

Holdings in Diamyd Medical as of August 31, 2016: 20 000 B shares.

Martina Widman

Director Clinical Development

Born in 1981. M.Sc. in Mechanical Engineering from the Royal Institute of Technology in Stockholm, with a specialization in Biomedical Engineering. Prior experience of clinical operation from the pharmaceutical industry. Joined Diamyd Medical in 2008.

Holdings in Diamyd Medical as of August 31, 2016: 0.

Anna Styrud

Chief Financial Officer

Born in 1961. B.Sc. in Business Administration from Uppsala University. Prior experience include Treasurer of Vasakronan AB and various positions in finance and control within real estate and engineering industry. Joined Diamyd Medical in 2010.

Holdings in Diamyd Medical as of August 31, 2016: 40 000 B shares.